Literature DB >> 6943372

Exogenous estrogens and other factors in the epidemiology of breast cancer.

J L Kelsey, D B Fischer, T R Holford, V A LiVoisi, E D Mostow, I S Goldenberg, C White.   

Abstract

In a hospital-based case-control study of the epidemiology of breast cancer undertaken in Connecticut from 1977 to 1979, there was no evidence of an increase in risk for breast cancer among women who had used oral contraceptives or estrogen-replacement therapy. In fact, there was some suggestion of a decrease in risk for breast cancer with increasing length of use of oral contraceptives. Higher than average risks were found among women who had never give birth to a child, women with a late age at menopause, women, with an early age at menarche, women who had given birth to their first child at a relatively late age, women with previous benign breast disease, and women with a history of breast cancer in a sister or mother. Heavy women were at high risk for premenopausal breast cancer. The association between heaviness and postmenopausal breast cancer was strongest among women who had had their last menstrual period more than 5 years before the diagnosis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6943372

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  27 in total

1.  Noncontraceptive hormone use and risk of breast cancer.

Authors:  C P Yang; J R Daling; P R Band; R P Gallagher; E White; N S Weiss
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

Review 2.  A risk-benefit assessment of estrogen therapy in postmenopausal women.

Authors:  M P Cust; K F Gangar; T C Hillard; M I Whitehead
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

Review 3.  Dietary prevention of breast cancer.

Authors:  D P Rose; J M Connolly
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

Review 4.  Induced abortion as cancer risk factor: a review of epidemiological evidence.

Authors:  L I Remennick
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

5.  The human breast and the ancestral reproductive cycle : A preliminary inquiry into breast cancer etiology.

Authors:  K Coe; L B Steadman
Journal:  Hum Nat       Date:  1995-09

Review 6.  Hormone replacement therapy and breast cancer. A review of current knowledge.

Authors:  L Bergkvist; I Persson
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

Review 7.  Hormone replacement therapy in the aged. A state of the art review.

Authors:  S Jacobs; T C Hillard
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

8.  Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand.

Authors:  R K McNee; B H Mason; L M Neave; R G Kay
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

9.  Cigarette smoking and benign breast disease.

Authors:  G S Berkowitz; P F Canny; V A Vivolsi; M J Merino; T Z O'Connor; J L Kelsey
Journal:  J Epidemiol Community Health       Date:  1985-12       Impact factor: 3.710

10.  p53 mutation, deprivation and poor prognosis in primary breast cancer.

Authors:  L Baker; P R Quinlan; N Patten; A Ashfield; L-J Birse-Stewart-Bell; C McCowan; J-C Bourdon; C A Purdie; L B Jordan; J A Dewar; L Wu; A M Thompson
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.